ArticleCancer medicine2024

Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma: A real-world cohort study in China.

Xiaoyan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.